+
QBIView and Polaris
Biologicals Intelligence and Technical Advisory
An independent reading of the evidence behind a biological product, and the route to register it in Brazil, Canada, the United States and the European Union.
The system
Two instruments that work as one. QBIView reads the evidence behind a biological product. Polaris maps the regulatory pathway the product has to follow in each market.
What it does
It answers one question for the client: is the evidence strong enough for this market, and what is the shortest route to registration from here? The report shows the evidence and the route. It never decides for the client and never promises approval.
The scope
Biological farm products: microbial inoculants, biostimulants, biological fertilizers and biocontrol. Markets: Brazil, Canada, the United States and the European Union. Clients: companies preparing a registration, distributors deciding whether to carry a product, and investors before they commit capital.
The scientific logic
QBIView grades the evidence across seven readiness layers, each scored on its own. Polaris states, for each answer, the regulation it is drawn from and the date of that source. A gap in the evidence is named together with the trial or data that would close it.
How it works
Step 1
Your product and its evidence
studies, trials, labels, dossiers
Step 2
QBIView
seven readiness layers, each scored on its own
Step 3
Polaris
classification and pathway in four markets
Step 4
You know where the evidence stands
which gaps to close, and the route to market
QBIView
Seven readiness layers
- 1Biological Validity
- 2Product Integrity
- 3Field Translation
- 4Regulatory Pathway
- 5Commercial Viability
- 6Organizational & IP Strength
- 7R&D and Governance
Polaris
Four markets, read side by side
Brazil
MAPA; ANVISA and IBAMA for new plant-protection products
Canada
CFIA and PMRA
United States
EPA for biopesticides and plant regulators; state departments of agriculture for fertilizers and biostimulants
European Union
EFSA and Member States for biocontrol; notified bodies for CE-marked biostimulants
Polaris shows where the same product faces different requirements in each market, and every answer names the official source and its date.

Page 1 of a QBIView report (sample).
What the client receives
One written report, with a downloadable PDF. Depending on the level, it holds:
- ✓Score by readiness layer
- ✓Critical blockers and priority gaps
- ✓Product classification in each market
- ✓Applicable regulations and registration pathway
- ✓Process requirements, step by step
- ✓Official source references, with dates
Regulatory information, not legal advice: every report closes with a reminder to confirm against the official source before filing.
Three levels of work
Prices in Canadian dollars, with HST added where it applies.
Level 1
Quick evidence check
CAD 120
per product and market
One product and one market: what the public and supplied evidence shows, and the main gaps. Completed online and returned as a QBIView report.
RequestLevel 2
Evidence review
CAD 2,500
per product
Every study read, the evidence graded, the gaps named, and the trial or data that would close each gap. Written and signed by a soil microbiologist, in English or Portuguese.
Contact usLevel 3
Evidence review and registration route
Quoted per market
Brazil and Canada first; the United States and the European Union on request
The evidence review, plus the route to registration: which agency, which parts of the dossier, what is still pending, and a realistic order of steps. Quadros Bio does not file dossiers; full dossier work is referred to a partner.
Contact usRegulatory monitoring
Polaris plans for companies that follow the regulations of several markets over time. Monitored against the United States Federal Register, the Canada Gazette, EFSA and EUR-Lex in the European Union, and MAPA's fertiliser legislation in Brazil. Each answer states the date of the source it cites. Prices in US dollars.
The Field's Voice
Have you used a biological product?
An anonymous questionnaire for growers on their experience with agricultural biologicals. Five sections, about ten minutes, and no product recommendation.
